Divi’s lab Q3 PAT seen up 82.3% YoY to Rs. 409.6 cr: ICICI Direct

Net Sales are expected to increase by 26.1 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs. 1,308.2 crore, according to ICICI Direct.

January 11, 2019 / 05:30 PM IST
Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its third quarter (October-December’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Divi’s lab to report net profit at Rs. 409.6 crore up 82.3% year-on-year (up 3% quarter-on-quarter).


Net Sales are expected to increase by 26.1 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs. 1,308.2 crore, according to ICICI Direct.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 56.4 percent Y-o-Y (down 0.8 percent Q-o-Q) to Rs. 510.2 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections